Liver Bioreactor Design Issues of Fluid Flow and Zonation, Fibrosis, and Mechanics: A Computational Perspective
Source abstract
Abstract
Tissue engineering, with the goal of repairing or replacing damaged tissue and organs, has continued to make dramatic science-based advances since its origins in the late 1980’s and early 1990’s. Such advances are always multi-disciplinary in nature, from basic biology and chemistry through physics and mathematics to various engineering and computer fields. This review will focus its attention on two topics critical for tissue engineering liver development: (a) fluid flow, zonation, and drug screening, and (b) biomechanics, tissue stiffness, and fibrosis, all within the context of 3D structures. First, a general overview of various bioreactor designs developed to investigate fluid transport and tissue biomechanics is given. This includes a mention of computational fluid dynamic methods used to optimize and validate these designs. Thereafter, the perspective provided by computer simulations of flow, reactive transport, and biomechanics responses at the scale of the liver lobule and liver tissue is outlined, in addition to how bioreactor-measured properties can be utilized in these models. Here, the fundamental issues of tortuosity and upscaling are highlighted, as well as the role of disease and fibrosis in these issues. Some idealized simulations of the effects of fibrosis on lobule drug transport and mechanics responses are provided to further illustrate these concepts. This review concludes with an outline of some practical applications of tissue engineering advances and how efficient computational upscaling techniques, such as dual continuum modeling, might be used to quantify the transition of bioreactor results to the full liver scale.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Liver physiology and pathology · 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Physical Sciences, MacEwan University, Edmonton, AB T5J 4S2, Canada
Computer Modelling Group Ltd., Calgary, AB T2L 2A6, Canada
Department of Physics and Experimental Oncology, University of Alberta, Edmonton, AB T6G 2J1, Canada
DIMEAS, Politecnico di Torino, Corso Duca degli Abruzzi 24, 10129 Torino TO, Italy
References (100+)
Show source-provided references
1. Lanza, R., Langer, R., and Vacanti, J. (2000). Principles of Tissue Engineering, Academic Press. [2nd ed.].
2. Palsson, B., and Bhatia, S. (2004). Tissue Engineering, Pearson-Prentice Hall.
3. Chaudhuri, J., and Al-Rubeai, M. (2005). Bioreactors for Tissue Engineering, Springer.10.1007/1-4020-3741-4 ↗
4. Sharma, K. (2010). Transport Phenomena in Biomedical Engineering: Artificial Organ Design and Development, and Tissue Engineering, McGraw-Hill.
5. Burdick, J., and Mauck, R. (2011). Biomaterials for Tissue Engineering Applications: A Review of the Past and Future Trends, Springer Wien.10.1007/978-3-7091-0385-2 ↗
6. Bioreactor technologies to support liver function In Vitro10.1016/j.addr.2014.02.011 ↗
7. Engineered livers for infectious diseases10.1016/j.jcmgh.2017.11.005 ↗
8. Advances in engineered liver models for investigating drug-induced liver injury10.1155/2016/1829148 ↗
9. Bioengineered liver models for drug testing and cell differentiation studies10.1016/j.jcmgh.2017.11.012 ↗
10. Advances in engineered human liver platforms for drug metabolism studies10.1124/dmd.118.083295 ↗
11. Emerging In Vitro liver technologies for drug metabolism and inter-organ interactions10.1089/ten.teb.2016.0031 ↗
12. Biomaterials for liver tissue engineering10.1007/s12072-013-9503-7 ↗
13. Ye, S., Boeter, J.W.B., Penning, L.C., Spee, B., and Schneeberger, K. (2019). Hydrogels for liver tissue engineering. Bioeng. Basel Switz., 6.10.3390/bioengineering6030059 ↗
14. Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies10.1080/03602530601093489 ↗
15. Recent advances in 2D and 3D In Vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME10.1007/s00204-013-1078-5 ↗
16. Effect of extracellular matrix topology on cell structure, function, and physiological responsiveness: Hepatocytes cultured in a sandwich configuration
17. 3D liver models on a microplatform: Well-defined culture, engineering of liver tissue and liver-on-a-chip10.1039/C5LC00611B ↗
18. Microengineered liver tissues for drug testing10.1177/2211068214566939 ↗
19. Chip-based liver equivalents for toxicity testing--organotypicalness versus cost-efficient high throughput10.1039/c3lc50240f ↗
20. Bioengineered humanized livers as better three-dimensional drug testing model system10.4254/wjh.v10.i1.22 ↗
21. Arias, M. (2009). The Liver: Biology and Pathology, Lippincott Williams and Wilkins.
22. The modular microarchitecture of human liver10.1002/hep.20764 ↗
23. Metabolic zonation of the liver: Regulation and implications for liver function10.1016/0163-7258(92)90055-5 ↗
24. Liver zonation: Novel aspects of its regulation and its impact on homeostasis10.3748/wjg.v20.i26.8491 ↗
25. Hepatocyte heterogeneity in the metabolism of carbohydrates10.1159/000468777 ↗
26. Hepatocyte heterogeneity in the metabolism of amino acids and ammonia10.1159/000468779 ↗
27. Distribution of enzymes of fatty acid and ketone body metabolism in periportal and perivenous rat-liver tissue10.1111/j.1432-1033.1983.tb07623.x ↗
28. Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver10.1016/S0306-3623(96)00183-8 ↗
29. Zonal liver cell heterogeneity: Effects of oxygen on metabolic functions of hepatocytes
30. Zonation of parenchymal and nonparenchymal metabolism in liver10.1146/annurev.nu.16.070196.001143 ↗
31. Oxygen: Modulator of metabolic zonation and disease of the liver10.1002/hep.510310201 ↗
32. Metabolic zonation of the liver: The oxygen gradient revisited10.1016/j.redox.2017.01.012 ↗
33. Oxygen uptake rates and liver-specific functions of hepatocyte and 3T3 fibroblast co-cultures10.1002/bit.21225 ↗
34. Novel human hepatic organoid model enables testing of drug-induced liver fibrosis In Vitro10.1016/j.biomaterials.2015.11.026 ↗
35. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease10.1038/srep25187 ↗
36. Human hepatic 3D spheroids as a model for steatosis and insulin resistance10.1038/s41598-018-32722-6 ↗
37. Spheroid-based three-dimensional liver-on-a-chip to investigate hepatocyte-hepatic stellate cell interactions and flow effects10.1039/c3lc50197c ↗
38. A 3D alcoholic liver disease model on a chip10.1039/C5IB00298B ↗
39. 3D spherical microtissues and microfluidic technology for multi-tissue experiments and analysis10.1016/j.jbiotec.2015.01.003 ↗
40. A perfusion incubator liver chip for 3D cell culture with application on chronic hepatotoxicity testing10.1038/s41598-017-13848-5 ↗
41. Constrained spheroids for prolonged hepatocyte culture10.1016/j.biomaterials.2015.11.036 ↗
42. Numerical investigations of hepatic spheroids metabolic reactions in a perfusion bioreactor10.3389/fbioe.2019.00221 ↗
43. Long-term In Vitro function of adult hepatocytes in a collagen sandwich configuration10.1021/bp00009a007 ↗
44. Oxygen uptake rates in cultured rat hepatocytes10.1002/bit.260401020 ↗
45. A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: Cell viability and tissue-specific functions10.1021/bp990128o ↗
46. Laminar-flow immediate-overlay hepatocyte sandwich perfusion system for drug hepatotoxicity testing10.1016/j.biomaterials.2009.07.022 ↗
47. Numerical model of fluid flow and oxygen transport in a radial-flow microchannel containing hepatocytes10.1115/1.2798043 ↗
48. Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor10.1002/bit.1071 ↗
49. Analysis of oxygen transport to hepatocytes in a flat-plate microchannel bioreactor10.1114/1.1415524 ↗
50. Formation of steady-state oxygen gradients In Vitro: Application to liver zonation10.1002/bit.10569 ↗
51. In Vitro zonation and toxicity in a hepatocyte bioreactor10.1093/toxsci/kfi052 ↗
52. Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human10.1016/j.bcp.2009.05.013 ↗
53. A microfluidic hepatic coculture platform for cell-based drug metabolism studies10.1016/j.bcp.2009.11.010 ↗
54. Dynamic interplay of flow and collagen stabilizes primary hepatocytes culture in a microfluidic platform10.1039/C4LC00071D ↗
55. A Microfabricated platform for generating physiologically-relevant hepatocyte zonation10.1038/srep26868 ↗
56. Metabolic patterning on a chip: Towards In Vitro liver zonation of primary rat and human hepatocytes10.1038/s41598-018-27179-6 ↗
57. Micropatterned cell-cell interactions enable functional encapsulation of primary hepatocytes in hydrogel microtissues10.1089/ten.tea.2013.0667 ↗
58. Engineering a perfusable 3D human liver platform from iPS cells10.1039/C6LC00598E ↗
59. A microfabricated array bioreactor for perfused 3D liver culture10.1002/bit.10143 ↗
60. Functional behavior of primary rat liver cells in a three-dimensional perfused microarray bioreactor10.1089/107632702760184745 ↗
61. Rat liver sinusoidal endothelial cells survive without exogenous VEGF in 3D perfused co-cultures with hepatocytes
62. Perfused multiwell plate for 3D liver tissue engineering10.1039/B913221J ↗
63. Co-regulation of primary mouse hepatocyte viability and function by oxygen and matrix10.1002/bit.25152 ↗
64. Capturing complex 3D tissue physiology In Vitro10.1038/nrm1858 ↗
65. Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor10.1124/dmd.115.063495 ↗
66. Quantitative assessment of population variability in hepatic drug metabolism using a perfused three-dimensional human liver microphysiological system10.1124/jpet.116.237495 ↗
67. Modeling therapeutic antibody-small molecule drug-drug interactions using a three-dimensional perfusable human liver coculture platform10.1124/dmd.116.071456 ↗
68. Integrated assessment of diclofenac biotransformation, pharmacokinetics, and omics-based toxicity in a three-dimensional human liver-immunocompetent coculture system10.1124/dmd.116.074005 ↗
69. A low shear stress modular bioreactor for connected cell culture under high flow rates10.1002/bit.22671 ↗
70. Flow-regulated glucose and lipid metabolism in adipose tissue, endothelial cell and hepatocyte cultures in a modular bioreactor10.1002/biot.201000009 ↗
71. Modular bioreactor for primary human hepatocyte culture: Medium flow stimulates expression and activity of detoxification genes10.1002/biot.201000326 ↗
72. Fluid dynamic modeling to support the development of flow-based hepatocyte culture systems for metabolism studies10.3389/fbioe.2016.00072 ↗
73. In Vitro liver zonation of primary rat hepatocytes10.3389/fbioe.2019.00017 ↗
74. Engineering quasi-vivo In Vitro organ models10.1007/978-1-4614-3055-1_9 ↗
75. Illa, X., Vila, S., Yeste, J., Peralta, C., Gracia-Sancho, J., and Villa, R. (2014). A novel modular bioreactor to In Vitro study the hepatic sinusoid. PLoS ONE, 9.10.1371/journal.pone.0111864 ↗
76. Online oxygen monitoring using integrated inkjet-printed sensors in a liver-on-a-chip system10.1039/C8LC00456K ↗
77. Resemblance of the human liver sinusoid in a fluidic device with biomedical and pharmaceutical applications10.1002/bit.26776 ↗
78. Layered long-term co-culture of hepatocytes and endothelial cells on a transwell membrane: Toward engineering the liver sinusoid10.1088/1758-5082/5/4/045008 ↗
79. Liver sinusoid on a chip: Long-term layered co-culture of primary rat hepatocytes and endothelial cells in microfluidic platforms10.1002/bit.25659 ↗
80. Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip10.1039/C6LC01374K ↗
81. Large-scale high-density culture of hepatocytes in a liver microsystem with mimicked sinusoid blood flow10.1002/term.2758 ↗
82. A novel high aspect ratio microfluidic design to provide a stable and uniform microenvironment for cell growth in a high throughput mammalian cell culture array10.1039/b410743h ↗
83. Nanoliter scale microbioreactor array for quantitative cell biology10.1002/bit.20745 ↗
84. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture10.1002/bit.21360 ↗
85. Microfluidic environment for high density hepatocyte culture10.1007/s10544-007-9116-9 ↗
86. Gori, M., Simonelli, M.C., Giannitelli, S.M., Businaro, L., Trombetta, M., and Rainer, A. (2016). Investigating nonalcoholic fatty liver disease in a liver-on-a-chip microfluidic device. PLoS ONE, 11.10.1371/journal.pone.0159729 ↗
87. Hepatic organoids for microfluidic drug screening10.1039/C4LC00531G ↗
88. A microfluidic 3D hepatocyte chip for drug toxicity testing10.1039/b900912d ↗
89. Yu, F., Hunziker, W., and Choudhury, D. (2019). Engineering microfluidic organoid-on-a-chip platforms. Micromachines, 10.10.3390/mi10030165 ↗
90. A New approach for fabricating collagen/ecm-based bioinks using preosteoblasts and human adipose stem cells10.1002/adhm.201500193 ↗
91. Development of liver decellularized extracellular matrix bioink for three-dimensional cell printing-based liver tissue engineering10.1021/acs.biomac.6b01908 ↗
92. Nguyen, D.G., Funk, J., Robbins, J.B., Crogan-Grundy, C., Presnell, S.C., Singer, T., and Roth, A.B. (2016). Bioprinted 3D primary liver tissues allow assessment of organ-level response to clinical drug induced toxicity In Vitro. PLoS ONE, 11.10.1371/journal.pone.0158674 ↗
93. Editor’s highlight: modeling compound-induced fibrogenesis In Vitro using three-dimensional bioprinted human liver tissues10.1093/toxsci/kfw169 ↗
94. Norona, L.M., Nguyen, D.G., Gerber, D.A., Presnell, S.C., Mosedale, M., and Watkins, P.B. (2019). Bioprinted liver provides early insight into the role of Kupffer cells in TGF-β1 and methotrexate-induced fibrogenesis. PLoS ONE, 14.10.1371/journal.pone.0208958 ↗
95. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting10.1073/pnas.1524510113 ↗
96. Microfluidic cell culture system studies and computational fluid dynamics10.1016/j.mcm.2010.01.024 ↗
97. Scaffold-free 3D bio-printed human liver tissue stably maintains metabolic functions useful for drug discovery
98. A microfluidic approach for In Vitro assessment of interorgan interactions in drug metabolism using intestinal and liver slices10.1039/c0lc00043d ↗
99. Microfluidics enables small-scale tissue-based drug metabolism studies with scarce human tissue10.1016/j.jala.2011.07.003 ↗
100. Hydrogel embedding of precision-cut liver slices in a microfluidic device improves drug metabolic activity10.1002/bit.23053 ↗